(HealthDay)—Rates of prostate-specific antigen (PSA) testing increased significantly after the 2017 U.S. Preventive Services Task Force (USPSTF) draft statement on prostate cancer screening, reversing trends that resulted ...
Dec 1, 2021
0
1
Cancer Council Australia and the Prostate Cancer Foundation of Australia yesterday released new draft guidelines to help GPs counsel men who ask about prostate cancer tests. They advise GPs to explain the pros and cons of ...
Dec 11, 2014
0
0
A new study indicates that higher prostate cancer death rates among black men in the US may be due to a higher risk of developing preclinical prostate cancer as well as a higher risk of that cancer progressing more quickly ...
Apr 24, 2017
0
1
Colonoscopy is one of the most effective cancer screening procedures available. Colon cancer grows very slowly and can be treated if caught early through screening. But, perhaps because of this success, older Americans are ...
Mar 13, 2013
0
0
(HealthDay)—Men who are uninsured or underinsured get advanced prostate cancer at nearly four times the national average and don't survive as long as other men with advanced disease, a new study says.
May 7, 2013
0
0
(Medical Xpress)—Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment.
May 10, 2013
0
0
Controversy over prostate cancer screening guidelines that discourage use of PSA tests did not significantly reduce use of the test, a five-year review of more than 275,000 visits at UT Southwestern Medical Center showed.
Oct 6, 2016
0
0
(HealthDay)—The five-year incidence rate of joint surgery in psoriatic arthritis (PsA) patients is twice as high as in the general population, and this rate has remained steady over time, according to a study published ...
Nov 25, 2019
0
0
Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, according to researchers ...
May 9, 2024
0
1
A new Phase III study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, shows that patients with active psoriatic arthritis (PsA) treated with Ustekinumab (UST) 90mg were more than ...
Jun 8, 2012
0
0
